Latest news with #HDFCMutualFund
Mint
2 days ago
- Business
- Mint
HDFC Mutual Fund raises stake in Glenmark Pharmaceuticals to 5.07%. Details here
HDFC Mutual Fund has increased its stake in Glenmark Pharmaceuticals, breaching the 5 percent ownership threshold, as per the company's regulatory filing on June 18, 2025. The move comes even as Glenmark disclosed recent regulatory scrutiny of its U.S. manufacturing facility by the United States Food and Drug Administration (USFDA). According to the filing, HDFC Mutual Fund purchased an additional 3.57 lakh equity shares of Glenmark Pharma, raising its holding by 0.13 percent. Prior to the transaction, the fund house held 1.39 crore shares, or 4.94 percent of the company. Post acquisition, its total shareholding stands at 1.43 crore shares, which translates to a 5.07 percent stake in the pharmaceutical major. The stake increase is seen as a mark of confidence in the company's fundamentals and long-term growth potential, especially amid recent regulatory developments. As per the March 2025 shareholding pattern, Glenmark's promoters continue to hold a dominant 46.65 percent stake in the company. In parallel with the stake hike, Glenmark Pharmaceuticals also updated the stock exchanges about a recent Good Manufacturing Practice (GMP) inspection conducted by the USFDA at its Monroe, North Carolina facility in the U.S. The inspection, which spanned from June 9 to June 17, 2025, culminated in the issuance of a Form 483 with five observations. The company was quick to clarify that the observations were procedural in nature and did not pertain to data integrity—an issue that often raises red flags in the pharmaceutical industry. In its exchange communication, Glenmark stated, 'The Company will work in close collaboration with the agency to address the observations and will respond to the USFDA within the stipulated timeline.' A Form 483 is typically issued when the FDA investigator identifies possible violations of the Food, Drug, and Cosmetic (FD&C) Act, but the absence of critical concerns such as data falsification is considered a relatively positive outcome. On the market front, Glenmark Pharma shares saw some volatility, falling by as much as 1.5 percent to touch a low of ₹ 1,634.55 on June 18. The stock is still around 11 percent below its 52-week high of ₹ 1,830.05, which it had touched in October 2025. However, it remains significantly above its 52-week low of ₹ 1,199.95, seen in June 2024. The recent price trajectory shows renewed investor interest, with the stock gaining 12.5 percent in June so far, following a 5.5 percent rise in May. This follows a choppy start to the year where the stock fell over 10 percent in April, surged 20.5 percent in March, and posted losses of 12 percent and 9.7 percent in February and January respectively. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
&w=3840&q=100)
Business Standard
11-06-2025
- Business
- Business Standard
Silver prices surge: Top reasons and what to expect in the months ahead
Silver prices have been on a run in the last few weeks, rising from around $29.5 an ounce (oz) to $36.6/oz. This 24 per cent rise from March 2025 levels has outpaced the run in gold prices, which climbed nearly 15 per cent during this period to $3,338/oz. The recent strength in silver prices, analysts at HDFC Mutual Fund wrote in a note, can be partly explained by investors positioning for the ratio to normalize after silver's prolonged underperformance, besides strong demand from the user industries. In the last one year, silver prices have moved up 26.24 per cent, underperforming the run in gold prices that gained nearly 45 per cent during this period, data shows. Gold-Silver ratio ranged around and crossed 100 in May 2025, showing significant undervaluation of silver relative to Gold. The ratio, which indicates how many grams of silver one can buy for one gram of gold, had crossed 100 only once in this century, during the Covid-19 pandemic when silver corrected sharply amid disrupted industrial activity. A higher Gold – Silver ratio indicates silver is cheaper, and investors typically use it to diversify the amount of precious metals that they hold in their portfolio. As on 9 June 2025, the ratio stood at 91.53, higher than the 10-year average of 81, analysts said. Demand for silver Usage-wise, silver has a 52 per cent demand from industrial applications, and one of the biggest demand growth driver is its use in clean energy applications such as solar energy and electric vehicles (EVs). Jewellery (at 18 per cent) and physical investment, coins & bars (21 per cent) were some of the other demand drivers for silver in the last 10 years (from 2015-2024). Solar sector demand As per estimates in the World Silver Survey 2025, silver industrial demand rose 4 per cent in 2024 to 681 million ounces (Moz), reaching a new record high for the fourth consecutive year. Clean energy requirements such as investment in grid infrastructure, vehicle electrification, and solar applications were key drivers. AI is another driver for silver demand, as consumer electronics shipments increased. Jewellery, silverware and investment demand could see varying levels of demand going ahead amid firm prices, analysts said. Global policies around clean energy and outlook for global trade, in this backdrop, assume relevance in estimating long-term demand for silver. "Solar and EV-related demand has been a key driver for silver, and most economies have taken a strong view towards continued growth in adoption of these technologies. Risks to global growth outlook from tariff related uncertainties translate to risks to silver demand," the HDFC Mutual Fund note said. Where are silver prices headed? On the technical charts, a rare 'Cup and Handle' pattern is forming not just on the weekly chart, but also on the multi-decade (yearly) chart, said Apurva Sheth, head of market perspectives & research at SAMCO Securities, signaling a powerful fractal setup in motion. 'The $35 level now stands out as a crucial breakout zone. A sustained close above this mark could clear the path towards all-time highs, potentially targeting the psychological $50 zone seen during silver's last euphoric run in 2011,' Sheth said. TECHNICAL CHART HERE G Chokkalingam, founder and head of research at Equinomics Research, too, sees a robust demand from the user industries continuing in the months ahead, which is likely to keep silver prices firm. 'Demand for silver from solar and EV industries is likely to stay firm going ahead. I expect silver prices to rise 20 per cent easily from here on in the next 6 – 12 months,' he said.
&w=3840&q=100)
Business Standard
27-05-2025
- Business
- Business Standard
Smallcap stock hits new high in weak market; up 70% from May-month low
Centum Electronics share price today Shares of Centum Electronics moved higher by 14 per cent to hit an all-time high of ₹2,582.40 on the BSE in Tuesday's intra-day trade in an otherwise weak market. The smallcap stock engaged in industrial products business surpassed its previous high of ₹2,446.10 touched on May 23, 2025. The stock has appreciated by 70 per cent from its current month low of ₹1,515.20 touched on May 9, 2025. It has been more-than-doubled or zoomed 126 per cent from its 3-month low of ₹1,140.15 touched on March 4, 2025. At 02:35 PM; Centum Electronics was trading 11 per cent higher at ₹2,510.80, as compared to 1.1 per cent decline in the BSE Sensex. Centum Electronics trades at 123% premium over its QIP price Centum Electronics in March 2025 completed a Qualified Institutional Placement (QIP) raising ₹210 crore. The company issued 1.81 million shares at a price of ₹1,160 each. Currently, the stock trades at a 123 per cent premium over its QIP price. Key investors included HDFC Mutual Fund – HDFC Manufacturing Fund and HDFC Defence Fund acquiring nearly 33 per cent of the shares offered. Subhkam Ventures and 3P India Equity Fund were allotted 29.76 per cent and 28.57 per cent, respectively, of the shares offered. Centum Electronics said the net proceeds will be used for repayment / pre-payment, in part or in full, of certain outstanding borrowings availed by the company, capital expenditure for purchase of new equipment and machinery and general purposes. What's driving the rally in Centum Electronics Centum Electronics on May 13, 2025 said that the company has a role to play in developing systems and subsystems for the Space-Based Surveillance, however there is no information available with the company regarding Government's directive to move up the satellite development schedule from four years to 12-18 months. The company had given clarification on news reports that the government has directed three private firms including Centum Electronics to move up their satellite development schedule from four years to 12-18 months. Strong Q4 results & robust order book For the January to March 2025 quarter (Q4FY25), Centum Electronics reported 24 per cent year-on-year (YoY) and 31 per cent quarter-on-quarter (QoQ) growth in consolidated revenue, driven by strong performance in high-margin Build-to-Spec (BTS) business for domestic Defence and Space customers. Consolidated earnings before interest, taxes, depreciation and amortisation (EBITDA) margin stood at 11.3 per cent, up 44 bps QoQ and 52 bps YoY, driven by higher billing in the BTS segment. The company reported profit after tax of ₹21.5 crore, against loss of ₹6.9 crore in a year ago quarter and loss of ₹19.3 crore in December 2024 quarter. Total order book at end of Q4FY25 stood at ₹1,736.4 crore. Standalone order book surged to ₹1,329.7 crore (vs ₹1,117.8 crore in FY24), led by strong BTS order inflow. New EMS customers have advanced to the qualification and NPI stage, positioning the business for strong revenue growth in FY26, the company said. About Centum Electronics Centum Electronics is in designing and manufacturing electronic systems and manufactures high-end electronic modules, subsystems and systems used in the aerospace, defence, and industrial electronics sectors. The company has delivered mission-critical electronics on almost all satellite programs of ISRO including the ambitious Chandrayaan and Mangalyaan projects and also delivered 300 to 500 components for almost every Indian space mission. The clientele base consists of reputed defence segment companies such as Space Application Centre, ISRO, DRDO's, ABB, Thales, and RAFAEL among others.
Time of India
21-05-2025
- Business
- Time of India
27 equity mutual funds offer over 25% CAGR in both 3 and 5 years. Have you added any to your portfolio?
Live Events Around 27 equity mutual funds have offered over 25% CAGR in both the last three and five years. There were around 199 equity mutual funds that completed five years of existence in the these 27 schemes, the maximum schemes were from HDFC Mutual Fund. There were around five schemes from the fund house, followed by three each from Invesco Mutual Fund, Motilal Oswal Mutual Fund, and Nippon India Mutual Fund. Two schemes each from Bandhan Mutual Fund, Franklin Templeton Mutual Fund, and JM Mutual Fund. Seven other fund houses had one scheme Read | Over 260 debt mutual funds beat fixed deposits rate in 2 years. Should you switch? Bandhan Core Equity Fund and Bandhan Small Cap Fund offered over 25% CAGR in both the last three and five years. Edelweiss Mid Cap Fund offered 27.45% and 34.46% CAGR in the last three and five years, and small cap funds from Franklin Templeton Mutual Fund - Franklin India Prima Fund and Franklin India Smaller Cos Fund - offered over 25% CAGR in the said schemes from HDFC Mutual Fund - HDFC ELSS Tax saver , HDFC Flexi Cap Fund, HDFC Focused 30 Fund, HDFC Mid-Cap Opportunities Fund, and HDFC Small Cap Fund - featured in the list of equity schemes that have offered over 25% CAGR in the said Value Fund gave 25.59% and 31.32% CAGR in the last three and five years respectively. Three funds from Invesco Mutual Fund - Invesco India Large & Mid Cap Fund, Invesco India Midcap Fund, and Invesco India Smallcap Fund gained over 25% in the mentioned time Flexicap Fund and JM Value Fund delivered over 25% CAGR in the same time periods. Mahindra Manulife Mid Cap Fund, the only scheme from Mahindra Manulife Mutual Fund, featured in the schemes - Motilal Oswal ELSS Tax Saver Fund, Motilal Oswal Large & Midcap Fund, and Motilal Oswal Midcap Fund - offered CAGR over 25% in the said time periods. Three schemes from Nippon India Mutual Fund were there in the list of schemes that gave over 25% CAGR in both the horizons. Quant Small Cap Fund offered 26.33% and 49.62% CAGR in the last three and five years, respectively. SBI Long Term Equity Fund, the oldest ELSS fund, offered 27.72% and 30.30% CAGR in the last three and five years, Read | HDFC Bank, Eternal among stocks bought and sold by SBI Mutual Fund in April Sundaram Mid Cap Fund offered 26.92% and 31.28% CAGR in the last three and five years, these 27 funds, Motilal Oswal Midcap Fund has offered the highest CAGR of around 31.93% in the last three years, whereas within the same universe, Quant Small Cap Fund has offered the highest CAGR of 49.62% in the last five considered all equity mutual fund categories. We considered regular and growth options. We calculated the CAGR over the last three and five the above exercise is not a recommendation. The exercise was done to find which equity schemes have offered over 25% CAGR in the last three and five years both. One should not make investment or redemption decisions based on the above should always invest based on their risk appetite, investment horizon, and goals.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Economic Times
19-05-2025
- Business
- Economic Times
BSE and Adani Enterprises among stocks that HDFC Mutual Fund bought and sold in April
HDFC Mutual Fund, the third largest mutual fund in India based on assets managed, added more stocks of BSE and 469 other stocks to its portfolio in April whereas reduced its stake in Adani Enterprises and 119 other stocks in the same period, according to the monthly data shared by Prime Database. Among the stocks where the fund house increased its allocation includes BSE, Hyundai Motor India, Power Grid Corporation of India, Adani Ports & Special Economic Zone, HDFC Bank, HCL Technologies, Eicher Motors, Bharti Airtel, Hindalco Industries, Yes Bank, and Eternal. Also Read | Sensex @82,300: Should mutual fund investors alter their investment strategy? The stocks where it reduced its stake included IRCTC, HUDCO, Federal Bank, ITC Hotels, ACC, Bank of India, Gail (India), Nippon Life AMC, Indian Energy Exchange, Radico Khaitan, Trent, Siemens, HAL, Tata Consumer Products, REC, IndusInd Bank, and SBI, and fund house did not add any new stock to its portfolio in the said time period. HDFC Mutual Fund made a complete exit from Blue Jet Healthcare. Around 10,671 shares of Blue Jet Healthcare were sold out from the portfolio worth Rs 0.94 crore. There were around 19 unique stocks in the portfolio of the fund house which included Bajaj Healthcare, BEML Land Assets, Delta Corporation, Diffusion Engineers, Epack Durables, Goodyear India, OCCL, Ramco Systems, TV Today Network, and Epack industry-wise holding of the fund house was highest in financial services of around 33.78%, 15.84% in consumer discretionary. Around 3.59% was in telecommunication, and 5.69% in energy, and 5.59% in Read | Railways PSU ETF delivers 16% in a week. Is this the right opportunity for portfolio diversification?In FMCG, the allocation was 4.16%, followed by services which had an allocation of 3.05%. The fund house had an allocation of 9.19% in healthcare, 7.87% in IT, and 8.65% in lowest allocation was in utilities of around 2.59%.The fund house had a total AUM of Rs 8.24 lakh crore as on April 30, 2025 and manages 134 schemes.
